X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tuberculosis (30) 30
humans (25) 25
index medicus (21) 21
tuberculosis, multidrug-resistant - drug therapy (18) 18
antitubercular agents - therapeutic use (17) 17
drug resistance (17) 17
adult (16) 16
female (16) 16
male (16) 16
middle aged (14) 14
care and treatment (13) 13
infectious diseases (12) 12
mycobacterium tuberculosis - drug effects (12) 12
adolescent (10) 10
drug resistance in microorganisms (9) 9
immunology (9) 9
microbial sensitivity tests (9) 9
multidrug-resistant tuberculosis (9) 9
sputum - microbiology (9) 9
young adult (9) 9
drug therapy (8) 8
medicine, general & internal (8) 8
multidrug resistant organisms (8) 8
research (8) 8
respiratory system (8) 8
risk factors (8) 8
treatment outcome (8) 8
aged (7) 7
antitubercular agents (7) 7
antitubercular agents - pharmacology (7) 7
medicine (7) 7
mycobacterium tuberculosis - isolation & purification (7) 7
treatment outcomes (7) 7
abridged index medicus (6) 6
analysis (6) 6
clinical outcomes (6) 6
drugs (6) 6
extensively drug-resistant tuberculosis - drug therapy (6) 6
microbiology (6) 6
tuberculosis, multidrug-resistant - epidemiology (6) 6
infectious and parasitic diseases (5) 5
meta-analysis (5) 5
mycobacterium-tuberculosis (5) 5
pulmonary tuberculosis (5) 5
rifampin (5) 5
risk (5) 5
tuberculosis, multidrug-resistant - microbiology (5) 5
tuberculosis, multidrug-resistant - mortality (5) 5
tuberculosis, pulmonary - drug therapy (5) 5
antitubercular agents - administration & dosage (4) 4
article (4) 4
clinical trials (4) 4
cohort studies (4) 4
disease control (4) 4
drug therapy, combination (4) 4
extensively drug-resistant tuberculosis (4) 4
latvia (4) 4
latvia - epidemiology (4) 4
management (4) 4
medical treatment (4) 4
metaanalysis (4) 4
patients (4) 4
proportional hazards models (4) 4
prospective studies (4) 4
treatment failure (4) 4
tuberculosis, multidrug-resistant - diagnosis (4) 4
and commentaries (3) 3
antibiotics (3) 3
articles and commentaries (3) 3
bacteria (3) 3
cohort (3) 3
drug administration schedule (3) 3
drug resistance, multiple, bacterial (3) 3
drug-resistance (3) 3
follow-up (3) 3
health (3) 3
health aspects (3) 3
kaplan-meier estimate (3) 3
odds ratio (3) 3
outcomes (3) 3
patient outcomes (3) 3
predictors (3) 3
program (3) 3
therapy (3) 3
usage (3) 3
adults (2) 2
aggressive regimens (2) 2
antimicrobial resistance (2) 2
coinfection (2) 2
cost (2) 2
cross-sectional studies (2) 2
data processing (2) 2
developing countries (2) 2
diagnosis (2) 2
diarylquinolines - therapeutic use (2) 2
directly observed therapy (2) 2
dosage and administration (2) 2
dots-plus (2) 2
drug susceptibility test (2) 2
estonia - epidemiology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9851, pp. 1406 - 1417
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 707 - 715
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2014, Volume 371, Issue 8, pp. 723 - 732
Journal Article
by Ahuja, Shama D and Ashkin, David and Avendano, Monika and Banerjee, Rita and Bauer, Melissa and Bayona, Jamie N and Becerra, Mercedes C and Benedetti, Anea and Burgos, Marcos and Centis, Rosella and Chan, Eward D and Chiang, Chen-Yuan and Cox, Helen and D'Ambrosio, Lia and DeRiemer, Kathy and Nguyen Huy Dung, [No Value] and Enarson, Donald and Falzon, Dennis and Flanagan, Katherine and Flood, Jennifer and Garcia-Garcia, Maria L and Gandhi, Neel and Granich, Reuben M and Hollm-Delgado, Maria G and Holtz, Timothy H and Iseman, Michael D and Jarlsberg, Leah G and Keshavjee, Salmaan and Kim, Hye-Ryoun and Koh, Won-Jung and Lancaster, Joey and Lange, Christophe and de lange, Wiel C. M and Leimane, Vaira and Leung, Chi Chiu and Li, Jiehui and Menzies, Dick and Migliori, Giovanni B and Mishustin, Sergey P and Mitnick, Carole D and Narita, Masa and O'Riordan, Philly and Pai, Madhukar and Palmero, Domingo and Park, Seung-kyu and Pasvol, Geoffrey and Pena, Jose and Perez-Guzman, Carlos and Quelapio, Maria I. D and Ponce-de-Leon, Alfredo and Riekstina, Vija and Robert, Jerome and Royce, Sarah and Schaaf, H. Simon and Seung, Kwonjune J and Shah, Lena and Shim, Tae Sun and Shin, Sonya S and Shiraishi, Yuji and Sifuentes-Osornio, Jose and Sotgiu, Giovanni and Strand, Matthew J and Tabarsi, Payam and Tupasi, Thelma E and van Altena, Robert and Van der Walt, Martie and Van der Werf, Tjip S and Vargas, Mario H and Viiklepp, Pirett and Westenhouse, Janice and Yew, Wing Wai and Yim, Jae-Joon and Collaborative Grp Meta-Anal and Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
PLOS MEDICINE, ISSN 1549-1676, 08/2012, Volume 9, Issue 8, p. e1001300
Journal Article
by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of... 
DRUG | SURGERY | SOUTH-AFRICA | BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | HIGH-RATES | MANAGEMENT | SAFETY | XDR-TB | REGIMENS | PROGRAM | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Medical services | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems
Journal Article
Journal Article
Bulletin of the World Health Organization, ISSN 0042-9686, 5/2007, Volume 85, Issue 5, pp. 393 - 394
Journal Article
European Respiratory Journal, ISSN 0903-1936, 09/2016, Volume 48, Issue suppl 60, p. OA3515
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 2015, Volume 21, Issue 3, pp. 409 - 416
Journal Article